Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
207.61
+0.48 (0.23%)
May 9, 2025, 2:45 PM CST
SHA:600436 Revenue
Zhangzhou Pientzehuang Pharmaceutical., had revenue of 3.14B CNY in the quarter ending March 31, 2025, a decrease of -0.92%. This brings the company's revenue in the last twelve months to 10.76B, up 1.50% year-over-year. In the year 2024, Zhangzhou Pientzehuang Pharmaceutical., had annual revenue of 10.79B with 7.25% growth.
Revenue (ttm)
10.76B
Revenue Growth
+1.50%
P/S Ratio
11.64
Revenue / Employee
3.79M
Employees
2,789
Market Cap
125.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.79B | 729.37M | 7.25% |
Dec 31, 2023 | 10.06B | 1.36B | 15.69% |
Dec 31, 2022 | 8.69B | 672.45M | 8.38% |
Dec 31, 2021 | 8.02B | 1.51B | 23.20% |
Dec 31, 2020 | 6.51B | 788.51M | 13.78% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |
Beijing Wantai Biological Pharmacy Enterprise | 1.89B |